STAT3 and hyper-IgE syndrome: Based on the severity of the clinical presentation in P8 and the functional characterization of the p.(Arg768*) mutant, it is tempting to conclude that the first STAT3 binding residue Tyr767 does not play a crucial role in maintaining physiological levels of STAT3 signaling and, thus, in protecting against the development of a HIES phenotype.